KANILAD õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

kanilad õhukese polümeerikattega tablett

medochemie limited - lakosamiid - õhukese polümeerikattega tablett - 200mg 168tk; 200mg 28tk; 200mg 14tk; 200mg 7tk; 200mg 56tk

ATryn Euroopa Liit - eesti - EMA (European Medicines Agency)

atryn

laboratoire francais du fractionnement et des biotechnologies - antithrombin alfa - antitrombiini iii defitsiit - antitrombootilised ained - atryn on näidustatud veenide trombemboolia profülaktikaks kaasasündinud antitrombiini puudulikkusega patsientide kirurgias. atryni manustatakse tavaliselt koos hepariini või madala molekulmassiga hepariiniga.

Segluromet Euroopa Liit - eesti - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Cevenfacta Euroopa Liit - eesti - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorraagilised ained - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

IMPLICOR 50MG/5MG õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

implicor 50mg/5mg õhukese polümeerikattega tablett

les laboratories servier - metoprolool+ivabradiin - õhukese polümeerikattega tablett - 50mg+5mg 100tk

IMPLICOR 50MG/7.5MG õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

implicor 50mg/7.5mg õhukese polümeerikattega tablett

les laboratoires servier - metoprolool+ivabradiin - õhukese polümeerikattega tablett - 50mg+7,5mg 56tk; 50mg+7,5mg 14tk; 50mg+7,5mg 98tk; 50mg+7,5mg 100tk; 50mg+7,5mg 28tk; 50mg+7,5mg 112tk